Day One Biopharmaceuticals: Mabcare Eligible to Receive Additional $1.152 Bln in Development, Regulatory and Commercial Success-Based Milestones
Day One生物製藥:Mabcare有資格獲得額外11.52億美元的研發、監管和商業成功里程碑獎勵
Day One Biopharmaceuticals: Mabcare Eligible to Receive Additional $1.152 Bln in Development, Regulatory and Commercial Success-Based Milestones
Day One生物製藥:Mabcare有資格獲得額外11.52億美元的研發、監管和商業成功里程碑獎勵
譯文內容由第三人軟體翻譯。